Digital Diagnostics vs Ibex Medical Analytics (2026)
The two strongest regulatory records in diagnostics, at opposite ends of the autonomy spectrum. Digital Diagnostics holds the only United States authorisation for an autonomous diagnosis, where the system issues the diabetic retinopathy result and no physician reads the image, backed by the best pivotal evidence design in this index with equity built into it. Ibex flags cancer on a slide a pathologist still signs, with three cancer types in routine clinical use, peer reviewed publication behind the deployment scale and the most complete published certification set of any vendor here. Neither competes with the other clinically. Together they mark the two poles a buyer should keep distinct: a product that decides needs pivotal evidence in the population it will serve, and a product that assists needs to show clinicians do better with it.
- It is the only United States authorised instance of a diagnosis made without a clinician reading the image, with the best pivotal evidence design in this index behind it.
- Equity was an input to that trial design rather than a disclosure added afterwards, which is rare anywhere here.
- There is a reimbursement pathway for the workflow rather than a value argument, which decides whether a primary care clinic runs the test at all.
- The published certification set is the most complete of any vendor in this index, and deployment evidence is verifiable through third parties rather than vendor claims.
- Three cancer types are in routine clinical use worldwide, with peer reviewed publication behind the deployment scale and a conservative cleared indication.
- For a laboratory signing out cancer diagnoses, an authorised detection product with that assurance record is the higher bar.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Digital Diagnostics and Ibex Medical Analytics are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Digital Diagnostics | Ibex Medical Analytics |
|---|---|---|
| Primary category | Diagnostics & Genomics | Digital Pathology AI |
| Founded | 2010 | 2016 |
| Headquarters | Coralville, Iowa, United States | Tel Aviv, Israel |
| Website | digitaldiagnostics.com | ibex-ai.com |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Digital Diagnostics its top capability grade on several axes, including AI Centrality, Autonomy and Oversight Model and Clinical and Operational Evidence. Set against Ibex Medical Analytics, Digital Diagnostics grades higher on Clinical and Operational Evidence, AI Governance and Bias Disclosure and Commercial Transparency. Its thinnest published disclosure sits on HIPAA and BAA Posture and Security Certifications and Trust Center. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index awards Ibex Medical Analytics its top capability grade on several axes, including AI Centrality, Autonomy and Oversight Model and Security Certifications and Trust Center. Set against Digital Diagnostics, Ibex Medical Analytics grades higher on several axes, including AI Safety and PHI Stewardship, HIPAA and BAA Posture and Security Certifications and Trust Center. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose Digital Diagnostics or Ibex Medical Analytics?
On the axes where the AI Health Index separates them, Digital Diagnostics grades higher on Clinical and Operational Evidence, AI Governance and Bias Disclosure and Commercial Transparency, and Ibex Medical Analytics grades higher on several axes, including AI Safety and PHI Stewardship, HIPAA and BAA Posture and Security Certifications and Trust Center. Ibex Medical Analytics leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do Digital Diagnostics and Ibex Medical Analytics differ most?
The widest separation the AI Health Index records between Digital Diagnostics and Ibex Medical Analytics is on Security Certifications and Trust Center, where Digital Diagnostics grades D and Ibex Medical Analytics grades A. That axis sits in the Regulatory and Compliance group, so it should carry the most weight for a buyer whose binding constraint is where regulatory exposure sits and who carries it.
Where do Digital Diagnostics and Ibex Medical Analytics grade the same?
The AI Health Index grades Digital Diagnostics and Ibex Medical Analytics the same on several axes, including AI Centrality, Autonomy and Oversight Model and Model and Technology Transparency. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
What have Digital Diagnostics and Ibex Medical Analytics not disclosed?
At the last review, at least one of Digital Diagnostics and Ibex Medical Analytics published thin or absent detail on HIPAA and BAA Posture and Security Certifications and Trust Center. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Diagnostics & Genomics page.
The two occupy opposite ends of the autonomy spectrum in diagnostics and that is the substance of the comparison: one issues a result with no clinician in the loop, the other flags suspicious tissue on a slide a pathologist signs. The evidence demanded should differ accordingly. Digital Diagnostics publishes no security attestation of any kind, and neither vendor publishes a business associate agreement template. Neither publishes subgroup performance beyond what the pivotal design captured, and in pathology staining and scanner variation between laboratories remains the largest uncontrolled variable.